STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.
STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the availability of its robust In Vitro Micronucleus Test service to meet the ...
NEW YORK, NY, UNITED STATES, January 26, 2026 /EINPresswire.com/ — STEMart, a US-based provider of comprehensive services for all phases of medical device ...
(MENAFN- EIN Presswire) EINPresswire/ -- STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the expansion of its genetic toxicology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results